Antibodies detection against hepatitis C virus in inhabitants of the South of Manabí-Ecuador
Abstract
The objective of this research is to determine the presence of antibodies against hepatitis C virus in the general population of the southern area of Manabí-Ecuador. The absence of HCV antibodies was demonstrated in the studied population, additional studies covering a larger population are neededReferences
Alvarado-Mora M V., Rebello Pinho JR. Epidemiological update of hepatitis B, C and delta in Latin America. Antivir Ther [Internet]. 2013 [citado 8 de mayo de 2019];18(3 PARTB):429-33. Disponible en: http://www.intmedpress.com/journals/avt/abstract.cfm?id=2595&pid=88 DOI: 10.3851/IMP2595 PMID 23792375 Google Académico
Organización Mundial de la Salud. Hepatitis C. Datos y Cifras [Internet]. 2019 [citado 29 de julio de 2019]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/hepatitis-c
World Health Organization. Global Hepatitis Report, 2017 [Internet]. Geneva: World Health Organization; 2017 [citado 29 de julio de 2019]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455-eng.pdf;jsessionid=8644315E7BF0F359E3765F6EFE92FE37?sequence=1
Instituto Nacional de Estadística y Censos [Internet]. [citado 29 de julio de 2019]. Disponible en: https://www.ecuadorencifras.gob.ec/institucional/home/
Hepatitis C: HCV Ab [Internet]. [citado 31 de julio de 2019]. Disponible en: https://www.diapro.it/index.php/products/elisa/hepatitis/hepatitis-c/hcv-ab-detail
World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ [Internet]. 2001;79(4):373-4. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/11357217 PMID 11357217 PMCID PMC2566407
Panduro A, Roman S. Need of righteous attitudes towards eradication of hepatitis C virus infection in Latin America. World J Gastroenterol [Internet]. 2016 [citado 8 de mayo de 2019];22(22):5137-42. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/27298556 DOI: 10.3748/wjg.v22.i22.5137 PMID 27298556 PMCID: PMC4893460 Google Académico
Kershenobich D, Razavi HA, Sánchez-Avila JF, Bessone F, Coelho HS, Dagher L, et al. Trends and projections of hepatitis C virus epidemiology in Latin America. Liver Int [Internet]. 2011 [citado 8 de mayo de 2019];31(Suppl. 2):18-29. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1478-3231.2011.02538.x DOI: 10.1111/j.1478-3231.2011.02538.x PMID 21651701 Google Académico
Tengan FM, Ibrahim KY, Dantas BP, Manchiero C, Magri MC, Bernardo WM. Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: A systematic review. BMC Infect Dis [Internet]. 2016 [citado 8 de mayo de 2019];16(1):663. Disponible en: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-016-1988-y DOI: 10.1186/s12879-016-1988-y PMID 27829381 PMCID PMC5103446 Google Académico
Lozano-Sepulveda S, Bryan-Marrugo O, Merino-Mascorro J, Rivas-Estilla AM. Approachability to the new anti-HCV direct acting antiviral agents in the Latin American context. Future Virol [Internet]. 2015;11(1):39-46. Disponible en: https://doi.org/10.2217/fvl.15.97 DOI: 10.2217/fvl.15.97 Google Académico
Traebert J, Fratoni KR de BP, Da Rosa LCD, Traebert E, Schneinder IJC. The burden of hepatitis C infection in a Southern Brazilian State. Rev Soc Bras Med Trop [Internet]. 2018 [citado 7 de mayo de 2019];51(5):670-3. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000500670&lng=en&tlng=en DOI: 10.1590/0037-8682-0098-2017 PMID: 30304275 Google Académico
Ramírez R, Fernández J, Guevara JG, Valderrama LA, Castro AL, Álvarez JA, et al. Prevalencia de anticuerpos contra el virus de hepatitis C en unidades de diálisis de Cali-Colombia. Rev Col Gastroenterol. 2010;(3):14-8. Disponible en: http://www.scielo.org.co/scielo.php?pid=S0120-99572010000100007&script=sci_abstract&tlng=pt Google Académico
Burguete-García AI, Conde-González CJ, Jiménez-Méndez R, Juárez-Díaz Y, Meda-Monzón E, Torres-Poveda K, et al. Hepatitis C seroprevalence and correlation between viral load and viral genotype among primary care clients in Mexico. Salud Publica Mex [Internet]. 2011 [citado 28 de septiembre de 2019];53(Suppl 1):S7-12. Disponible en: http://saludpublica.mx/index.php/spm/article/view/5018/10005 PMID 21877076 Google Académico
Valdespino JL, Conde-González CJ, Olaiz-Fernández G, Palma O, Kershenobich D, Sepúlveda J. Seroprevalencia de la hepatitis C en adultos de México: ¿Un problema de salud pública emergente? Salud Publica Mex [Internet]. 2007 [citado 28 de septiembre de 2019];49(Suppl. 3):s395-403. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342007000900011 Google Académico
Ministerio de Salud de Argentina. Implementación de Unidades Centinela Hepatitis Virales [Internet]. [citado 28 de septiembre de 2019]. Disponible en: http://www.hepatitisviral.com.ar/wp-content/uploads/2017/05/doc_tecnic_uc.pdf
Ximenes RA, Pereira LMB, Martelli CMT, Merchán-Hamann E, Stein AT, Figueiredo GM, et al. Methodology of a nationwide cross-sectional survey of prevalence and epidemiological patterns of hepatitis A, B and C infection in Brazil. Cad Saude Publica [Internet]. 2010 [citado 28 de septiembre de 2019];26(9):1693-704. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2010000900003&lng=en&tlng=en DOI: 10.1590/s0102-311x2010000900003 PMID 20877930 Google Académico
González R, Soza A, Hernández V, Pérez RM, Alvarez M, Morales A, et al. Incidence and prevalence of hepatitis C virus infection in Chile. Ann Hepatol [Internet]. 2005 [citado 28 de septiembre de 2019];4(2):127-30. Disponible en: https://www.sciencedirect.com/science/article/pii/S1665268119320769?via%3Dihub PMID 16010246 Google Académico
Robinson JW, Rosas M, Guzman F, Patarroyo ME, Moreno A. Comparison of prevalence of anti-hepatitis C virus antibodies in differing South American populations. J Med Virol [Internet]. 1996 [citado 27 de septiembre de 2019];50(2):188-92. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/8915886 DOI: 10.1002/(SICI)1096-9071(199610)50:2<188::AID-JMV13>3.0.CO;2-I PMID 8915886 Google Académico
Hyams KC, Phillips IA, Moran AY, Tejada A, Wignall FS, Escamilla J. Seroprevalence of hepatitis C antibody in Peru. J Med Virol [Internet]. 1992 [citado 28 de septiembre de 2019];37(2):127-31. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/1378483 DOI: 10.1002/jmv.1890370210 PMID 1378483 Google Académico
Muller GY, Zabaleta ME, Arminio A, Colmenares CJ, Capriles FI, Bianco NE, et al. Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int [Internet]. 1992 [citado 28 de septiembre de 2019];41(4):1055-8. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/1381002 DOI: 10.1038/ki.1992.160 PMID 1381002 Google Académico
Blitz‐Dorfman L, Monsalve F, Porto L, Weir J, Arteaga M, Padrón G, et al. Epidemiology of hepatitis C virus in Western Venezuela: Lack of specific antibody in indian communities. J Med Virol [Internet]. julio de 1994 [citado 28 de septiembre de 2019];43(3):287-90. Disponible en: http://doi.wiley.com/10.1002/jmv.1890430317 DOI: 10.1002/jmv.1890430317 PMID 7523583 Google Académico
Copyright (c) 2019 Elsa Noralma Lucas-Parrales, Anita M Murillo Zavala, Yelisa E Duran-Pincay
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Kasmera journal is registered under a Creative Commons an Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0), available at: https://creativecommons.org/licenses/by-nc-sa/4.0/deed.en; which guarantees the freedom to share-copy and redistribute the material in any medium or format and adapt-remix, transform and build from the material, provided that the name of the authors, the Department of Infectious and Tropical Diseases, Zulia´s University and Kasmera Journal, you must also provide a link to the original document and indicate if changes have been made.
The Department of Infectious and Tropical Diseases, University of Zulia and Kasmera Journal do not retain the rights to published manuscript and the contents are the sole responsibility of the authors, who retain their moral, intellectual, privacy and publicity rights. The guarantee on the intervention of the manuscript (revision, correction of style, translation, layout) and its subsequent dissemination is granted through a license of use and not through a transfer of rights, which represents the Kasmera Journal and Department Infectious Diseases, University of Zulia are exempt from any liability that may arise from ethical misconduct by the authors.
Kasmera is considered a green SHERPA/RoMEO journal, that is, it allows self-archiving of both the pre-print (draft of a manuscript) and the post-print (the corrected and peer-reviewed version) and even the final version (layout as it will be published in the journal) both in personal repositories and in institutional and databases.